These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 12195633)

  • 1. Beneficial effect of climatic therapy on inflammatory arthritis at Tiberias Hot Springs.
    Hashkes PJ
    Scand J Rheumatol; 2002; 31(3):172-7. PubMed ID: 12195633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dead Sea and Tiberias as health resort areas for patients suffering from different types of arthritis].
    Sukenik S; Abu-Shakra M; Kudish S; Flusser D
    Harefuah; 2006 Feb; 145(2):117-22, 165. PubMed ID: 16509416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
    Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A
    Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spa therapy for ankylosing spondylltis at the Dead Sea.
    Codish S; Dobrovinsky S; Abu Shakra M; Flusser D; Sukenik S
    Isr Med Assoc J; 2005 Jul; 7(7):443-6. PubMed ID: 16011060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis.
    Zink A; Thiele K; Huscher D; Listing J; Sieper J; Krause A; Gromnica-Ihle E; von Hinueber U; Wassenberg S; Genth E; Schneider M;
    J Rheumatol; 2006 Jan; 33(1):86-90. PubMed ID: 16395755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
    Antoni CE; Kavanaugh A; Kirkham B; Tutuncu Z; Burmester GR; Schneider U; Furst DE; Molitor J; Keystone E; Gladman D; Manger B; Wassenberg S; Weier R; Wallace DJ; Weisman MH; Kalden JR; Smolen J
    Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Physical and balneologic therapy of chronic rheumatic diseases].
    Ott VR
    Internist (Berl); 1967 Jul; 8(7):258-64. PubMed ID: 4922480
    [No Abstract]   [Full Text] [Related]  

  • 8. [Spa therapy in rheumatology. Indications based on the clinical guidelines of the French National Authority for health and the European League Against Rheumatism, and the results of 19 randomized clinical trials].
    Françon A; Forestier R
    Bull Acad Natl Med; 2009 Jun; 193(6):1345-56; discussion 1356-8. PubMed ID: 20120164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is a long-term high-intensity exercise program effective and safe in patients with rheumatoid arthritis? Results of a randomized controlled trial.
    de Jong Z; Munneke M; Zwinderman AH; Kroon HM; Jansen A; Ronday KH; van Schaardenburg D; Dijkmans BA; Van den Ende CH; Breedveld FC; Vliet Vlieland TP; Hazes JM
    Arthritis Rheum; 2003 Sep; 48(9):2415-24. PubMed ID: 13130460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic usefulness of synovial vascular morphology in chronic arthritis. A systematic survey of 100 cases.
    Cañete JD; Rodríguez JR; Salvador G; Gómez-Centeno A; Muñoz-Gómez J; Sanmartí R
    Semin Arthritis Rheum; 2003 Jun; 32(6):378-87. PubMed ID: 12833246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MonitorNet: the Italian multi-centre observational study aimed at estimating the risk/benefit profile of biologic agents in real-world rheumatology practice.
    Sfriso P; Salaffi F; Montecucco CM; Bombardieri S; Todesco S
    Reumatismo; 2009; 61(2):132-9. PubMed ID: 19633800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease activity-guided rituximab therapy in rheumatoid arthritis: the effects of re-treatment in initial nonresponders versus initial responders.
    Thurlings RM; Vos K; Gerlag DM; Tak PP
    Arthritis Rheum; 2008 Dec; 58(12):3657-64. PubMed ID: 19035505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of rheumatic patients in a warm climate abroad].
    Forseth KØ
    Tidsskr Nor Laegeforen; 2007 Feb; 127(4):449-52. PubMed ID: 17304274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Objective evaluation of complex balneotherapy based on radon in ankylosing spondylitis and rheumatoid arthritis (summary index of functions)].
    Zielke VA; Just L; Schubert M; Tautenhahn B
    Z Physiother; 1973; 25(2):113-7. PubMed ID: 4721089
    [No Abstract]   [Full Text] [Related]  

  • 16. [Physical therapy in rheumatic diseases].
    Callies R
    Z Gesamte Inn Med; 1977 Nov; 32(21):585-9. PubMed ID: 304282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responsiveness to anti-tumour necrosis factor alpha therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients.
    van der Pouw Kraan TC; Wijbrandts CA; van Baarsen LG; Rustenburg F; Baggen JM; Verweij CL; Tak PP
    Ann Rheum Dis; 2008 Apr; 67(4):563-6. PubMed ID: 18042642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticytokine therapy in non-rheumatoid arthritis indications in 2009.
    Villa-Forte A
    Curr Opin Rheumatol; 2009 May; 21(3):251-5. PubMed ID: 19342955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of refractory inflammatory monoarthritis in ankylosing spondylitis by intraarticular injection of infliximab.
    Schatteman L; Gyselbrecht L; De Clercq L; Mielants H
    J Rheumatol; 2006 Jan; 33(1):82-5. PubMed ID: 16292792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial.
    Matteson EL; Weyand CM; Fulbright JW; Christianson TJ; McClelland RL; Goronzy JJ
    Rheumatology (Oxford); 2004 May; 43(5):619-25. PubMed ID: 14983105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.